Edition:
United States

Aspen Technology Inc (AZPN.OQ)

AZPN.OQ on NASDAQ Stock Exchange Global Select Market

68.37USD
22 Nov 2017
Change (% chg)

$-0.11 (-0.16%)
Prev Close
$68.48
Open
$68.43
Day's High
$69.07
Day's Low
$68.36
Volume
104,198
Avg. Vol
173,778
52-wk High
$69.07
52-wk Low
$51.47

Select another date:

Thu, Oct 26 2017

BRIEF-Aspen Technology Q1 non-GAAP earnings per share $0.53

* Aspen technology announces financial results for the first quarter of fiscal 2018

UK anti-trust regulator investigates South Africa's Aspen Pharmacare

JOHANNESBURG Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

UK anti-trust regulator investigates S.Africa's Aspen Pharmacare

JOHANNESBURG, Oct 13 Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

South Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

UPDATE 1-S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

CORRECTED-South Africa's Aspen Pharmacare flags jump in full-year profit

JOHANNESBURG, Aug 30 South African drugmaker Aspen Pharmacare said on Wednesday that it expects full-year profit to climb by as much as 48 percent from last year when it was hit by a writedown on its Venezuelan business.

BRIEF-Aspen Technology Q4 non-GAAP earnings per share $0.79

* Aspen Technology announces financial results for the fourth quarter and fiscal year 2017

Select another date: